Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (191-200 of 288) with videos related to

Pageof 29
Sort By:
Plos One|November 1, 2017
Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected malesCristina Rovelli, Andrea Poli, Laura Galli, et al.
BMC Infectious Diseases|January 13, 2017
A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markersMatteo Bonato, Laura Galli, Laura Passeri, et al.
International Journal of Antimicrobial Agents|March 4, 2023
Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimenRossana Scutari, Laura Galli, Claudia Alteri, et al.
HIV Medicine|April 18, 2026
Three settings, one goal: Performance of different HIV testing strategies at a tertiary centre in MilanAngelo Roberto Raccagni, Riccardo Lolatto, Nicolò Capra, et al.
Epidemiology and Infection|February 6, 2020
Molecular epidemiology of HIV-1 infection in immigrant population in northern ItalyCaterina Sagnelli, Caterina Uberti-Foppa, Sabrina Bagaglio, et al.
AIDS (London, England)|July 2, 2014
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findingsDavid A Cooper, Jayvant Heera, Prudence Ive, et al.
Journal of the International AIDS Society|November 15, 2014
Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT studyVincenzo Spagnuolo, Laura Galli, Alba Bigoloni, et al.
AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patientsJoseph C Gathe, Gerald Pierone, Peter Piliero, et al.
Antiviral Therapy|April 14, 2010
Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapyAntonella Castagna, Laura Galli, Carlo Torti, et al.
Pageof 29

Showing results (191-200 of 288) with videos related to

Sort By:
Pageof 29
Plos One|November 1, 2017
Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected malesCristina Rovelli, Andrea Poli, Laura Galli, et al.
BMC Infectious Diseases|January 13, 2017
A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markersMatteo Bonato, Laura Galli, Laura Passeri, et al.
International Journal of Antimicrobial Agents|March 4, 2023
Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimenRossana Scutari, Laura Galli, Claudia Alteri, et al.
HIV Medicine|April 18, 2026
Three settings, one goal: Performance of different HIV testing strategies at a tertiary centre in MilanAngelo Roberto Raccagni, Riccardo Lolatto, Nicolò Capra, et al.
Epidemiology and Infection|February 6, 2020
Molecular epidemiology of HIV-1 infection in immigrant population in northern ItalyCaterina Sagnelli, Caterina Uberti-Foppa, Sabrina Bagaglio, et al.
AIDS (London, England)|July 2, 2014
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findingsDavid A Cooper, Jayvant Heera, Prudence Ive, et al.
Journal of the International AIDS Society|November 15, 2014
Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT studyVincenzo Spagnuolo, Laura Galli, Alba Bigoloni, et al.
AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
AIDS Research and Human Retroviruses|February 1, 2007
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patientsJoseph C Gathe, Gerald Pierone, Peter Piliero, et al.
Antiviral Therapy|April 14, 2010
Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapyAntonella Castagna, Laura Galli, Carlo Torti, et al.
Pageof 29